Adiposity per se may not be specific enough for the risk assessment of BC, while metabolic parameters of health (e.g., insulin resistance indices such as HOMA-IR or fasting insulin) may be more biologically accurate for BC risk stratification, exhibiting a strong impact on the risk in postmenopausal women [4,5,6]. This evidence concerns the gene INS and breast cancer.